Across TCGA pan-cancer cohorts, MIR548O RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of MIR548O’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where MIR548O RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR548O is over-expressed in tumor, although a few such as READ and COAD show the opposite, repressed pattern.

KIRC, READ, and COAD are the cancer types where MIR548O tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR548O RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	All	+0.132	.005	3	view →
READ	All	III,IV	−0.615	.023	2	view →
COAD	Male	II,III,IV	−0.224	.009	2	view →
HNSC	Male	II,III,IV	+0.145	.023	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: MIR548O RNA expression & survival · all MIR548O data types